Skip to content

Clinical trials

Phase 2 Growth Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Growth Disorders Phase: Phase 2 Country / region: United States Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20151
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's National Research Institute1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
National Human Genome Research Institute (NHGRI)1
Nemours Children's Clinic1
QED Therapeutics, a BridgeBio company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Growth Disorders5
Dwarfism3
Achondroplasia1
Bone Diseases1
Congenital Abnormalities1
Mucopolysaccharidosis IV1
Musculoskeletal Diseases1
Nutrition Disorders1
Osteochondrodysplasias1
Puberty, Delayed1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.